Health

In a bold move, a group of 40 hospital-based clinicians from Skagit Valley Hospital and Cascade Valley Hospital in Washington state have decided to file for unionization. This group, consisting of doctors, physician assistants, and nurse practitioners, is seeking to join the Union of American Physicians and Dentists (UAPD) in order to address various workplace
The recent French prospective ENVIE study has shed light on the protective properties of the monoclonal antibody nirsevimab (Beyfortus) in young infants against respiratory syncytial virus (RSV) related hospitalizations. This study, published in the New England Journal of Medicine, reported promising results which indicate that nirsevimab is effective in preventing RSV-associated bronchiolitis in infants under
A recent study presented at the American Society of Clinical Oncology (ASCO) meeting highlighted the potential of liposomal gemcitabine in combination with pembrolizumab for the treatment of advanced solid tumors. Dr. Charles Farber, from Atlantic Hematology Oncology, delved into the feasibility and tolerability of this innovative therapy during the conference. The use of liposomal gemcitabine
It has been suggested that the use of extended infusion antibiotics could provide optimal outcomes for patients with bloodstream infections. Sara Karaba, MD, PhD, MHS, from Johns Hopkins University School of Medicine believes that this strategy offers “the most bang for its buck.” By carefully considering the dosage and administration of antibiotics, healthcare providers may
The use of GLP-1 receptor agonists has been associated with a lower risk of developing several obesity-related cancers, according to a recent retrospective analysis of electronic health records. The study, led by Nathan Berger, MD, of Case Western Reserve University in Cleveland, delved into the potential impact of GLP-1s on cancer prevention among individuals with
A recent multisite retrospective cohort study conducted by Elyse Kharbanda, MD, MPH, and colleagues at the HealthPartners Institute in Bloomington, Minnesota, found that receiving an mRNA COVID-19 vaccine during the first trimester of pregnancy did not lead to an increased risk of major structural birth defects. The study revealed that major structural birth defects occurred